Case Study: AMAG Pharmaceuticals, Inc. achieves 97% fewer helpdesk password resets and Mass. 201 compliance with Imprivata OneSign

A Imprivata Case Study

Preview of the AMAG Pharmaceuticals, Inc. Case Study

Discover the Cure for Password Woes

AMAG Pharmaceuticals, a Lexington-based biopharmaceutical firm with about 300 employees across two locations and a nationwide sales force, was struggling with password proliferation as it adopted a dozen hosted SaaS applications. Staff managed an average of nine passwords (managers up to 15), faced frequent lockouts and growing helpdesk load of up to 100 monthly password-reset calls, while regulatory requirements such as SOX, 21 CFR Part 11 and Massachusetts 201 CMR 17 increased the compliance risk.

AMAG deployed Imprivata OneSign single sign-on across its sites for a quick, low-overhead rollout that avoided additional server management. The SSO solution provided fast access to hosted apps, encrypted credentials to meet Mass. 201 CMR 17, eliminated user password headaches and reduced helpdesk password resets by 97% (to about two per month), freeing IT to focus on higher-value work.


Open case study document...

AMAG Pharmaceuticals, Inc.

Nathan McBride

Executive Director of IT, AMAG Pharmaceuticals, Inc.


Imprivata

138 Case Studies